| Date Filed | Type | Description |
| 06/05/2023 |
4
| Powell Andrew Kenneth William (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 15,750 options to buy
@ $8.7, valued at
$137k
Granted 4,660 restricted stock units
@ $0
Exercised 4,507 restricted stock units
@ $0 |
|
| 01/20/2023 |
4
| Powell Andrew Kenneth William (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Gifted 4,000 shares
@ $0 |
|
| 06/13/2022 |
4
| Powell Andrew Kenneth William (Director) has filed a Form 4 on Silverback Therapeutics, Inc.|
Txns:
| Granted 18,000 options to buy
@ $4.18, valued at
$75.2k
|
|
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/21/2021 |
4
| Powell Andrew Kenneth William (Director) has filed a Form 4 on Silverback Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $28.83, valued at
$432.5k
|
|
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2020 |
4
| Powell Andrew Kenneth William (Director) has filed a Form 4 on Silverback Therapeutics, Inc.|
Txns:
| Granted 21,009 options to buy
@ $21, valued at
$441.2k
|
|
| 12/07/2020 |
3/A
| Powell Andrew Kenneth William (Director) has filed a Form 3/A on Silverback Therapeutics, Inc. |
| 12/03/2020 |
3
| Powell Andrew Kenneth William (Director) has filed a Form 3 on Silverback Therapeutics, Inc. |
| 10/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2020 |
4
| Powell Andrew Kenneth William (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 16,500 options to buy
@ $1.41, valued at
$23.3k
Exercised 7,333 restricted stock units
@ $0 |
|
| 06/02/2020 |
4
| Powell Andrew Kenneth William (Director) has filed a Form 4 on LANDEC CORP \CA\|
Txns:
| Granted 8,303 options to buy
@ $0 |
|
| 05/29/2020 |
4
| Powell Andrew Kenneth William (Director) has filed a Form 4 on LANDEC CORP \CA\|
Txns:
| Granted 6,000 shares
@ $10.99, valued at
$65.9k
Exercised 6,000 restricted stock units
@ $0 |
|
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2020 |
4
| Powell Andrew Kenneth William (Director) has filed a Form 4 on Synthorx, Inc.|
Txns:
| Disposed/sold 27,015 options to buy
@ $14, valued at
$378.2k
Disposed/sold 6,389 options to buy
@ $12.4, valued at
$79.2k
|
|
| 10/17/2019 |
4
| Powell Andrew Kenneth William (Director) has filed a Form 4 on LANDEC CORP \CA\|
Txns:
| Granted 2,200 options to buy
@ $0 |
|
| 06/10/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/30/2019 |
4
| Powell Andrew Kenneth William (Director) has filed a Form 4 on LANDEC CORP \CA\|
Txns:
| Exercised 2,915 shares
@ $9.91, valued at
$28.9k
Exercised 2,915 restricted stock units
@ $0
Granted 6,000 options to buy
@ $0 |
|
| 01/31/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/14/2019 |
4
| Powell Andrew Kenneth William (Director) has filed a Form 4 on LANDEC CORP \CA\|
Txns:
| Bought 525 shares
@ $11.62, valued at
$6.1k
|
|
| 12/21/2018 |
4
| Powell Andrew Kenneth William (Director) has filed a Form 4 on Synthorx, Inc.|
Txns:
| Granted 27,015 options to buy
@ $14, valued at
$378.2k
|
|
| 12/21/2018 |
3
| Powell Andrew Kenneth William (Director) has filed a Form 3 on Synthorx, Inc. |
| 10/22/2018 |
3
| Powell Andrew Kenneth William (Director) has filed a Form 3 on LANDEC CORP \CA\ |
| 06/08/2018 |
4
| Powell Andrew Kenneth William (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 8,000 options to buy
@ $18.35, valued at
$146.8k
|
|
| 05/17/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2017 |
4
| Powell Andrew Kenneth William (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 8,000 options to buy
@ $24.58, valued at
$196.6k
|
|
| 01/26/2017 |
4
| Powell Andrew Kenneth William (Director) has filed a Form 4 on Aclaris Therapeutics, Inc. |
| 01/26/2017 |
3
| Powell Andrew Kenneth William (Director) has filed a Form 3 on Aclaris Therapeutics, Inc. |
|